Cargando…

Clinical efficacy and safety of sirolimus in systemic lupus erythematosus: a real-world study and meta-analysis

OBJECTIVE: To provide real-world data and summarize current clinical evidence on the efficacy and safety of sirolimus in active systemic lupus erythematosus (SLE) patients. METHODS: This was a prospective real-world clinical study. Included SLE patients should have Systemic Lupus Erythematosus Disea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Liying, Wu, Chanyuan, Hong, Ruping, Sun, Yiduo, Qian, Junyan, Zhao, Jiuliang, Wang, Qian, Tian, Xinping, Wang, Yanhong, Li, Mengtao, Zeng, Xiaofeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493251/ https://www.ncbi.nlm.nih.gov/pubmed/32973935 http://dx.doi.org/10.1177/1759720X20953336

Ejemplares similares

Sirolimus versus tacrolimus for systemic lupus erythematosus treatment: results from a real-world CSTAR cohort study
por: Jiang, Nan, et al.
Publicado: (2022)

Clinical efficacy of tacrolimus in systemic lupus erythematosus with various manifestations: a real-world study
por: Bai, Wei, et al.
Publicado: (2022)

Long-Term Survival and Death Causes of Systemic Lupus Erythematosus in China: A Systemic Review of Observational Studies
por: Wang, Ziqian, et al.
Publicado: (2015)

The Challenges and Future Perspective for the Management of Systemic Lupus Erythematosus in China: A Concise Annual Report of 2020
por: Tian, Xinping, et al.
Publicado: (2022)

Annual Direct Cost and Cost-Drivers of Systemic Lupus Erythematosus: A Multi-Center Cross-Sectional Study from CSTAR Registry
por: Wang, Haiyan, et al.
Publicado: (2023)

Chinese SLE Treatment and Research Group (CSTAR) Registry 2009–2019: Major Clinical Characteristics of Chinese Patients with Systemic Lupus Erythematosus
por: Li, Mengtao, et al.
Publicado: (2021)

2022 Chinese guideline for the management of pregnancy and reproduction in systemic lupus erythematosus
por: Tian, Xinping, et al.
Publicado: (2023)

The diagnostic and prognostic value of growth differentiation factor‐15 in systemic lupus erythematosus‐associated pulmonary arterial hypertension
por: Qian, Junyan, et al.
Publicado: (2023)

Progress in the Pathogenesis and Treatment of Neuropsychiatric Systemic Lupus Erythematosus
por: Wang, Minhui, et al.
Publicado: (2022)

Impact of pregnancy in patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: case series and literature review
por: Li, Mucong, et al.
Publicado: (2022)

Clinical Characteristics of Systemic Lupus Erythematosus with Cirrhosis
por: You, Hanxiao, et al.
Publicado: (2020)

Clinical efficacy and safety of sirolimus in childhood-onset systemic lupus erythematosus in real world
por: Zhang, Lei, et al.
Publicado: (2022)

Progressive Multifocal Leukoencephalopathy in a Patient with Systemic Lupus Erythematosus
por: Qiao, Lin, et al.
Publicado: (2022)

Clinical Characteristics and Prognoses of Patients With Systemic Lupus Erythematosus Hospitalized for Pulmonary Infections
por: Yang, Yanli, et al.
Publicado: (2021)

Efficacy and safety of immunosuppressive agents for adults with lupus nephritis: a systematic review and network meta-analysis
por: Jiang, Nan, et al.
Publicado: (2023)

Characteristics and Long-term Outcomes of Patients with Lupus-related Protein-losing Enteropathy: A Retrospective Study
por: Peng, Liying, et al.
Publicado: (2020)

Exploring the risk factors and prognosis of transverse myelitis in systemic lupus erythematosus
por: Wang, Minhui, et al.
Publicado: (2022)

Baseline Characteristics and Risk Factors of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus Patients
por: Huang, Can, et al.
Publicado: (2016)

Chinese SLE Treatment and Research Group Registry (CSTAR) XIII: prevalence and risk factors for chronic scarring alopecia in patients with systemic lupus erythematosus
por: Xiang, Yirong, et al.
Publicado: (2021)

Improve quality of patient care for systemic lupus erythematosus in China by enhancing the construction of Centers of Excellence
por: Li, Mengtao, et al.
Publicado: (2023)

Identification of 6 dermatomyositis subgroups using principal component analysis‐based cluster analysis
por: Zhu, Huiyi, et al.
Publicado: (2019)

Long-term Outcomes of Patients with Systemic Lupus Erythematosus: A Multicenter Cohort Study from CSTAR Registry
por: Wang, Ziqian, et al.
Publicado: (2021)

Validation of the REVEAL Prognostic Models in Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension
por: Qu, Jingge, et al.
Publicado: (2021)

Clinical Experience of Sirolimus Regarding Efficacy and Safety in Systemic Lupus Erythematosus
por: Eriksson, Per, et al.
Publicado: (2019)

Risk assessment in systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study
por: Wang, Qian, et al.
Publicado: (2022)

Programmed Cell Death Pathways in the Pathogenesis of Idiopathic Inflammatory Myopathies
por: Shi, Jia, et al.
Publicado: (2021)

Clinical Analysis of 61 Systemic Lupus Erythematosus Patients With Intestinal Pseudo-Obstruction and/or Ureterohydronephrosis: A Retrospective Observational Study
por: Xu, Na, et al.
Publicado: (2015)

A prognostic model for systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study
por: Qu, Jingge, et al.
Publicado: (2023)

Factors Associated With Renal Involvement in Primary Sjögren's Syndrome: A Meta-Analysis
por: Hong, Ruping, et al.
Publicado: (2020)

Clinical Features and Outcomes of Neuropsychiatric Systemic Lupus Erythematosus in China
por: Zhang, Shangzhu, et al.
Publicado: (2021)

Development and external validation of a prediction model for venous thromboembolism in systemic lupus erythematosus
por: You, Hanxiao, et al.
Publicado: (2023)

Chinese Systemic Lupus Erythematosus Treatment and Research Group Registry VI: Effect of Cigarette Smoking on the Clinical Phenotype of Chinese Patients with Systemic Lupus Erythematosus
por: Xu, Dong, et al.
Publicado: (2015)

Sex differences in systemic lupus erythematosus (SLE): an inception cohort of the Chinese SLE Treatment and Research Group (CSTAR) registry XVII
por: Gui, Yinli, et al.
Publicado: (2022)

Immunoglobulin A Isotype of Antiphospholipid Antibodies Does Not Provide Added Value for the Diagnosis of Antiphospholipid Syndrome in a Chinese Population
por: Hu, Chaojun, et al.
Publicado: (2020)

Extra-criteria clinical manifestations of antiphospholipid antibody should not be ignored
por: Huang, Can, et al.
Publicado: (2022)

RheumCloud App: A Novel Mobile Application for the Management of Rheumatic Diseases Patients in China
por: Huang, Can, et al.
Publicado: (2022)

Myocardial involvement is not rare in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis/clinically amyopathic dermatomyositis: a retrospective study
por: Zhou, Shuang, et al.
Publicado: (2022)

Risk factors for avascular necrosis in patients with systemic lupus erythematosus: a multi-center cohort study of Chinese SLE Treatment and Research Group (CSTAR) Registry XXII
por: Cheng, Cheng, et al.
Publicado: (2023)

Chinese SLE Treatment and Research Group Registry (CSTAR) XIV: the subjective well-being of patients with systemic lupus erythematosus
por: Shi, Yue, et al.
Publicado: (2022)

Clinical Characteristics of Adult Patients with Systemic Vasculitis: Data of 1348 Patients from a Single Center
por: Li, Jing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cerrc3rar83ocbtdq32blgtju0